Abstract

Human blastocysts are comprised of the first three cell lineages of the embryo: trophectoderm, epiblast and primitive endoderm, all of which are essential for early development and organ formation. However, due to ethical concerns and restricted access to human blastocysts, a comprehensive understanding of early human embryogenesis is still lacking. To bridge this knowledge gap, a reliable model system that recapitulates early stages of human embryogenesis is needed. Here we developed a three-dimensional (3D), two-step induction protocol for generating blastocyst-like structures (EPS-blastoids) from human extended pluripotent stem (EPS) cells. Morphological and single-cell transcriptomic analyses revealed that EPS-blastoids contain key cell lineages and are transcriptionally similar to human blastocysts. Furthermore, EPS-blastoids are similar with human embryos that were cultured for 8 or 10 days in vitro, in terms of embryonic structures, cell lineages and transcriptomic profiles. In conclusion, we developed a scalable system to mimic human blastocyst development, which can potentially facilitate the study of early implantation failure that induced by developmental defects at early stage.

Details

Title
Generation of human blastocyst-like structures from pluripotent stem cells
Author
Fan, Yong 1   VIAFID ORCID Logo  ; Min Zheying 2 ; Samhan, Alsolami 3 ; Ma Zhenglai 1 ; Zhang, E 4 ; Chen, Wei 2 ; Zhong Ke 1 ; Pei Wendi 2 ; Kang Xiangjin 1 ; Zhang Puyao 2 ; Wang, Yongliang 5 ; Zhang, Yingying 1 ; Zhan Linfeng 4 ; Zhu, Haiying 1 ; An Chenrui 1 ; Li, Rong 2 ; Qiao Jie 2   VIAFID ORCID Logo  ; Tan, Tao 4 ; Li, Mo 3   VIAFID ORCID Logo  ; Yang, Yu 6   VIAFID ORCID Logo 

 Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Department of Gynecology and Obstetrics, Key Laboratory for Major Obstetric Diseases of Guangdong Province, Guangzhou, China (GRID:grid.417009.b) (ISNI:0000 0004 1758 4591) 
 Peking University Third Hospital, Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing, China (GRID:grid.411642.4) (ISNI:0000 0004 0605 3760) 
 King Abdullah University of Science and Technology (KAUST), Biological and Environmental Sciences and Engineering Division, Thuwal, Kingdom of Saudi Arabia (GRID:grid.45672.32) (ISNI:0000 0001 1926 5090) 
 Institute of Primate Translational Medicine, Kunming University of Science and Technology, Yunnan Key Laboratory of Primate Biomedical Research, Kunming, China (GRID:grid.218292.2) (ISNI:0000 0000 8571 108X) 
 China University of Mining and Technology, School of Mechanics and Civil Engineering, Beijing, China (GRID:grid.411510.0) (ISNI:0000 0000 9030 231X) 
 Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Department of Gynecology and Obstetrics, Key Laboratory for Major Obstetric Diseases of Guangdong Province, Guangzhou, China (GRID:grid.417009.b) (ISNI:0000 0004 1758 4591); Peking University Third Hospital, Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology and Key Laboratory of Assisted Reproduction, Ministry of Education, Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing, China (GRID:grid.411642.4) (ISNI:0000 0004 0605 3760); Peking University Third Hospital, Clinical Stem Cell Research Center, Beijing, China (GRID:grid.411642.4) (ISNI:0000 0004 0605 3760) 
Publication year
2021
Publication date
2021
Publisher
Springer Nature B.V.
e-ISSN
20565968
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2569483259
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.